U.S. federal trademark · Serial No. 99145505
Software as a service (SAAS) services featuring software for generating, curating, and summarizing patient-specific target and variant intelligence for personalized therapy design, and automating literature review and report generation for patient cases in the field of drug development, custom drug development, and personalized anti-sense RNA drug development; Software as a service (SAAS) services featuring software for using artificial intelligence (AI) for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for managing laboratory workflows and inventory, and managing patient intake and case files in the field of drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for electronic storage, version control, and indexing of protocols, results, and case documentation and analytics in the field of drug development, custom drug development, and personalized anti-sense RNA drug development, all of the foregoing using artificial intelligence (AI)
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.